Secondary prevention care and effect: Total and low-density lipoprotein cholesterol levels and lipid-lowering drug use in women and men after incident myocardial infarction - The Tromsø Study 1994-2016

European Journal of Cardiovascular Nursing : Journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology
Laila Arnesdatter HopstockTom Wilsgaard

Abstract

Secondary prevention guidelines after myocardial infarction (MI) are gender neutral, but underutilisation of treatment in women has been reported. We investigated the change in total and low-density lipoprotein (LDL) cholesterol levels and lipid-lowering drug (LLD) use after first-ever MI in a population-based study. We followed 10,005 participants (54% women) attending the Tromsø Study 1994-1995 and 8483 participants (55% women) attending the Tromsø Study 2007-2008 for first-ever MI up to their participation in 2007-2008 and 2015-2016, respectively. We used linear and logistic regression models to investigate sex differences in change in lipid levels. A total of 395 (MI cohort I) and 132 participants (MI cohort II) had a first-ever MI during 1994-2008 and 2007-2013, respectively. Mean change in total cholesterol was -2.34 mmol/L (SD 1.15) in MI cohort I, and in LDL cholesterol was -1.63 mmol/L (SD 1.12) in MI cohort II. Men had a larger decrease in lipid levels compared to women: the linear regression coefficient for change was -0.33 (95% confidence interval [CI] -0.51 to -0.14) for total cholesterol and -0.21 (95% CI -0.37 to -0.04) for LDL cholesterol, adjusted for baseline lipid value, age and cohort. Men had 73% higher odd...Continue Reading

References

Mar 10, 2001·JAMA : the Journal of the American Medical Association·U StenestrandUNKNOWN Swedish Register of Cardiac Intensive Care (RIKS-HIA)
Jun 24, 2004·Journal of General Internal Medicine·Jeffrey J EllisA Mark Fendrick
Nov 6, 2007·European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·Ian GrahamUNKNOWN European Heart Network (EHN)
Nov 6, 2007·European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·Ian GrahamUNKNOWN European Atherosclerosis Society (EAS)
Mar 17, 2009·European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·Kornelia KotsevaUNKNOWN EUROASPIRE Study Group
Mar 9, 2011·European Heart Journal·Raffaele BugiardiniUNKNOWN Canadian Acute Coronary Syndrome Registry I and II Investigators
Apr 20, 2012·European Journal of Preventive Cardiology·Marie Therese CooneyIan Graham
Jul 4, 2012·The American Journal of Medicine·Sripal BangaloreUNKNOWN Get with the Guidelines Steering Committee and Investigators
Oct 11, 2012·Current Problems in Cardiology·Eveline Oestreicher Stock, Rita Redberg
Jun 5, 2013·European Journal of Cardiovascular Nursing : Journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology·Lisa DullaghanDonna Fitzsimons
Oct 16, 2014·Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række·Jarle JortveitSigrun Halvorsen
Nov 13, 2014·The Medical Journal of Australia·Jay B Thakkar, Clara K Chow
Jan 31, 2015·Journal of the American College of Cardiology·Pratik B SandesaraLaurence Sperling
Feb 18, 2015·European Journal of Preventive Cardiology·Kornelia KotsevaUNKNOWN on behalf of the EUROASPIRE Investigators
Sep 8, 2016·European Journal of Preventive Cardiology·Massimo F PiepoliAntonio Pelliccia
Dec 4, 2016·BMC Public Health·Bente MorsethLone Jørgensen

❮ Previous
Next ❯

Software Mentioned

SAS

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.